HKPD — Cellyan Biotechnology Co., Ltd
$0.1000+4.17%
Last close: · regular session
Last 60 sessions
HKPD closed at $0.1000 (+4.17%) on Oct 23, 2026. Active shelf registration (F-3, Jun 2026). Float: 14.5M shares. Latest SEC filing: 6-K on Oct 21, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for HKPD in the TickerWise workspace.
Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical support, including customs clearance, drug registration, and warehousing facilities. Cellyan Biotechnology caters to a diverse clientele, which includes logistics partners for e-commerce platforms, various merchants, and pharmaceutical distributors. Founded in 2023, the company is based in Yau Tong, Hong Kong. It was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and officially adopted the name Cellyan Biotechnology Co., Ltd in December 2025.
Company profile
- Sector: Healthcare
- Industry: Medical - Distribution
- Country: HK
- Exchange: NASDAQ Capital Market
- Employees: 27
- Website: http://www.9zt.hk
Latest SEC filings for HKPD
Latest HKPD news
- Cellyan Biotechnology announces 1-for-20 reverse stock split Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.